arginine has been researched along with Bile Duct Cancer in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Fu, X; Gu, S; Han, X; He, J; He, W; Qiu, Y; Yan, M; Yan, X; Zhou, Q | 1 |
| Chenvidhya, D; Fujii, T; Honjo, S; Jedpiyawongse, A; Matharit, M; Miwa, M; Ohshima, K; Ohta, E; Sripa, B; Srivatanakul, P; Tanaka, H; Tanaka, M; Viwatthanasittiphong, C; You, G; Zeng, L | 1 |
| Furukawa, K; Kato, A; Miyazaki, M; Ohtsuka, M; Shimizu, H; Suzuki, D; Uno, H; Yoshitomi, H | 1 |
| Furukawa, K; Kato, A; Kimura, F; Miyazaki, M; Ohtsuka, M; Shimizu, H; Suzuki, D; Yoshidome, H; Yoshitomi, H | 1 |
| Gotohda, N; Kinoshita, T; Konishi, M; Nakagohri, T; Shirakawa, H; Takahashi, S | 1 |
1 trial(s) available for arginine and Bile Duct Cancer
| Article | Year |
|---|---|
Immunonutrition suppresses acute inflammatory responses through modulation of resolvin E1 in patients undergoing major hepatobiliary resection.
Topics: Aged; Arginine; Bile Duct Neoplasms; Carcinoma; Dietary Supplements; Eicosapentaenoic Acid; Enteral Nutrition; Female; Hepatectomy; Humans; Male; Middle Aged; Nucleotides; Postoperative Complications; Prospective Studies | 2016 |
4 other study(ies) available for arginine and Bile Duct Cancer
| Article | Year |
|---|---|
Higher content of microcystin-leucine-arginine promotes the survival of intrahepatic cholangiocarcinoma cells via regulating SET resulting in the poorer prognosis of patients.
Topics: Arginine; Bile Duct Neoplasms; Cell Proliferation; Cholangiocarcinoma; Disease-Free Survival; DNA-Binding Proteins; Female; Histone Chaperones; Humans; Leucine; Male; Microcystins; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Factors; RNA Interference; RNA, Messenger; RNA, Small Interfering | 2021 |
Combined effects of polymorphisms of DNA-repair protein genes and metabolic enzyme genes on the risk of cholangiocarcinoma.
Topics: Alanine; Arginine; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cysteine; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; Genotype; Glutamine; Glutathione Transferase; Histidine; Humans; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Risk Assessment; Risk Factors; Serine; Valine; X-ray Repair Cross Complementing Protein 1 | 2013 |
Effects of perioperative immunonutrition on cell-mediated immunity, T helper type 1 (Th1)/Th2 differentiation, and Th17 response after pancreaticoduodenectomy.
Topics: Aged; Aged, 80 and over; Arginine; Bile Duct Neoplasms; Cell Differentiation; Concanavalin A; Diet; Enteral Nutrition; Fatty Acids, Omega-3; Female; Humans; Immunity, Cellular; Immunosuppression Therapy; Interferon-gamma; Intraoperative Care; Lymphocyte Activation; Male; Neoplasm Staging; Pancreatic Neoplasms; Pancreaticoduodenectomy; Phytohemagglutinins; Preoperative Care; RNA; RNA, Messenger; Th1 Cells; Th2 Cells | 2010 |
Compliance with and effects of preoperative immunonutrition in patients undergoing pancreaticoduodenectomy.
Topics: Aged; Aged, 80 and over; Arginine; Bile Duct Neoplasms; Drug Combinations; Duodenal Neoplasms; Enteral Nutrition; Fatty Acids, Omega-3; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pancreaticoduodenectomy; Patient Compliance; Postoperative Complications; Preoperative Care; Prospective Studies; RNA; Time Factors; Treatment Outcome | 2012 |